Hospital Award

By: News Release
Jun 30th, 2017

Crossing Rivers Health wins coveted Studer Group Excellence in Patient Care Award 


Hospitals today are tasked with constantly providing higher quality care at a lower cost. Every aspect of the patient experience must be approached with a passion for excellence and an eye toward efficiency and effectiveness. It’s not easy. That’s why receiving an Excellence in Patient Care Award—presented by Studer Group®, a Huron solution—is considered an honor in the industry.


Crossing Rivers Health will be awarded that honor in August. Specifically, the Prairie du Chien, Wisconsin, organization is being recognized for exemplary results related to responsiveness of staff as measured by the HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) survey. Organizations receiving this award achieved a ranking at or above the 90th percentile for patients discharged in 2016 as measured by the HCAHPS patient experience survey required by the Centers for Medicare & Medicaid Services.


Bill Sexton, Chief Executive Officer, commented, “At Crossing Rivers Health, we are committed to providing a positive experience for patients. This award is a reflection of the hard work and dedication of our employees. Through our mission, we strive to provide excellent care to all those we serve. We are proud to be your bridge to wellness.”


Excellence in Patient Care Awards are presented annually to a select group of organizations from Studer Group’s partner base of hospitals, health systems, and physician organizations. To be eligible for an award, an organization must demonstrate outstanding performance and achievement in patient care, employee engagement, or physician engagement.


The awards will be presented at the 15th annual What’s Right in Health Care conference, which will take place August 1-3, 2017, in Chicago, Illinois. The conference attracts administrative and clinical healthcare professionals from the U.S., Canada, Australia, and beyond.


What’s Right in Health Care aims to improve healthcare for patients, physicians, and staff through peer-to-peer sharing of leading practices. Presenters will share the strategies and tactics contributing to their top results in areas such as patient safety, emergency department wait times, and employee satisfaction.


“We are so proud of all the healthcare organizations that are receiving awards for their outstanding results on this survey,” says Debbie Ritchie, president of Studer Group. “Excellent HCAHPS performance is a true reflection of their commitment to engage with patients and provide them the absolute best possible care. We are grateful to work with such passionate, purpose-driven organizations.”   



Crossing Rivers Health wins Intalere Healthcare Achievement Award (photo attached)

Recognized for outstanding operational improvements to ensure best-in-class healthcare delivery



Crossing Rivers Health has been recognized by Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, as an Intalere Healthcare Achievement Award winner in the category of Community Impact and Innovation. Through this annual awards program, Intalere recognizes successful initiatives its members implement to enhance quality and operations, improve patient satisfaction and increase community awareness and education.


“Intalere members are successfully creating incremental value and greater operational efficiencies through constant innovation and transfer of best practices,” said Julius Heil, Intalere President and CEO. “We are honored to recognize our members for their accomplishments, and believe that through collaboration and engagement, we can positively impact healthcare delivery for the future.”


Crossing Rivers Health’s winning project, Advanced 3D Mammography, involved providing the best quality care and healthcare technology available in the United States within a 50 mile radius of Prairie du Chien, at no additional costs to patients. 


“We are honored to be recognized by Intalere for the work we have done to improve healthcare delivery at our facility,” said Tim Clark, Medical Imaging Director at Crossing Rivers Health. “We are dedicated to making improvements to benefit our patients, staff and the community; and we appreciate the national recognition of our efforts to make advanced 3D mammograms available to all women at no extra cost.”


Four representatives from Crossing Rivers Health were presented the award during a ceremony held during Intalere’s Elevate 2017, in Orlando, Florida- Tim Clark, Medical Imaging Director; Allison Riter, Radiologic Technologist; Sasha Dull, Chief Development Officer; Krista Zimmerman, Materials Management Director. The winning project will also be featured in a professional banner session and included in a best practices compendium.



Not your average PSA.


Prostate-specific antigen, or PSA, is a blood test used to help detect prostate cancer. An elevated level of the antigen in your blood might indicate you have cancer. Seems pretty straight forward, right? Dr. Logan Hoxie, MD, FACS, Urologist at Crossing Rivers Health, an expert on this topic, shares his opinion on the debate surrounding the PSA test.


“There is growing controversy regarding the PSA test and whether or not it is necessary for younger, otherwise healthy men,” explained Dr. Hoxie. “Deciding whether or not to do PSA testing is a choice you should make with your doctor. The pros and cons to having the test will have different meaning to different people.”


Dr. Hoxie shared his honest insight on the pros and cons surrounding PSA testing. Is it worth it?


Risk of false positive...Or a false negative: “As with any test, there is a risk that it will return a false positive result. And if that happens, it causes a lot of unnecessary anxiety and could cloud a person’s judgment regarding future treatment,” Dr. Hoxie commented. “The rate of false positive results is relatively low; however, there is still a chance. Conversely, some men with cancer will return normal PSA levels, potentially creating a false sense of security.”


Many prostate cancers don’t need treatment: “This is probably the biggest argument against PSA testing. Prostate cancer can be very slow growing and never affect a man in his lifetime. But, sometimes, the cancer is highly aggressive and the PSA test can reveal it when there’s still time to cure it,” Dr. Hoxie said. “The side effects of cancer treatment are costly, both monetarily and physically, so we have to be very careful deciding who to treat and who not to treat. If the cancer has little or no chance of progressing, then there is no reason to put a man through the treatments.”


Prostate cancer treatment can result in erectile dysfunction, urinary incontinence or bowel dysfunction. “In most cases of elevated PSA levels, we will conduct other tests to make sure it’s cancer we’re dealing with, not enlarged prostate or a prostate infection causing the concerning test results,” Dr. Hoxie said. “And, just because your first PSA test is elevated, does not mean you have cancer. Depending on your levels, your physician will repeat your PSA every six months to determine if the test is a false positive or a true upward trend.”


So who should really get a PSA test? In general, Dr. Hoxie recommends PSA testing for men who are at greatest risk for prostate cancer. Risk factors to consider include:


  • Age: Men between the ages of 50 and 70 are most recommended to get a PSA test.
  • Race/ethnicity: Men of African-American and Caribbean descent are more likely to develop, and die from, prostate cancer.
  • Family history: Those who have family members with prostate cancer are more likely to develop it themselves.


Think you may be at risk for prostate cancer? To schedule a PSA test with one of the urologists at Crossing Rivers Health in Prairie du Chien, call 608.357.2525 or visit